Pirnabine
Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]
References
|
|
Plant cannabinoids |
|
|
Cannabinoid metabolites |
|
|
Endogenous cannabinoids |
|
|
Synthetic cannabinoid
receptor agonists |
Classical cannabinoids
(Dibenzopyrans)
|
|
|
Nonclassical cannabinoids
|
|
|
Benzoylindoles
|
|
|
Naphthoylindoles
|
|
|
Naphthylmethylindoles
|
JWH-175 · JWH-184 · JWH-185 · JWH-192 · JWH-194 · JWH-195 · JWH-196 · JWH-197 · JWH-199
|
|
Phenylacetylindoles
|
|
|
Naphthoylpyrroles
|
|
|
Eicosanoids
|
|
|
Others
|
|
|
|
Allosteric modulators of
cannabinoid receptors |
|
|
Endocannabinoid
activity enhancers |
|
|
Cannabinoid receptor
antagonists and
inverse agonists |
|
|